INS and obesity disorder: Increased local concentration of glucocorticoids rather than systematically elevated glucocorticoid levels impairs insulin and leptin sensitivity, which ultimately results in metabolic disease, including Cushing’s syndrome, obesity and type 2 diabetes [4].